Prehliadač alebo jeho nastavenia nie sú podporované.

Praktik.ai používa moderné webové technológie kvôli bezpečnosti, rýchlosti a spoľahlivému prihlasovaniu. Tento prehliadač ich nepodporuje alebo blokuje JavaScript, preto sa aplikácia nemusí správne načítať.

Aktualizujte prosím Chrome, Edge, Firefox alebo Safari na najnovšiu verziu a stránku potom obnovte.

Ak používate Windows 7, Windows 8 alebo Windows 8.1, Chrome a Edge už nemusia ponúkať novú verziu. V takom prípade použite novšie zariadenie alebo kontaktujte podporu Praktik.ai.

Prohlížeč nebo jeho nastavení nejsou podporované.

Praktik.ai používá moderní webové technologie kvůli bezpečnosti, rychlosti a spolehlivému přihlašování. Tento prohlížeč je nepodporuje nebo blokuje JavaScript, proto se aplikace nemusí správně načíst.

Aktualizujte prosím Chrome, Edge, Firefox nebo Safari na nejnovější verzi a stránku potom obnovte.

Pokud používáte Windows 7, Windows 8 nebo Windows 8.1, Chrome a Edge už nemusí nabízet novou verzi. V takovém případě použijte novější zařízení nebo kontaktujte podporu Praktik.ai.

Your browser or its settings are not supported.

Praktik.ai uses modern web technologies for security, speed, and reliable sign-in. This browser does not support them, or JavaScript is blocked, so the app may not load correctly.

Please update Chrome, Edge, Firefox, or Safari to the latest version and then reload this page.

If you use Windows 7, Windows 8, or Windows 8.1, Chrome and Edge may no longer offer a newer version. In that case, use a newer device or contact Praktik.ai support.

Not effective Commission Decision

Rozhodnutie č. 108/2002

Important dates

Declared: 11. februára 2002
Approved: 11. februára 2002
Effective from: 13. februára 2002
Effective until: 20. apríla 2021

Documents and links

Commission Decision

of 11 February 2002

for restocking the bluetongue vaccine Community bank

(notified under document number C(2002) 432)

(Text with EEA relevance)

(2002/108/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Directive 2000/75/EC of 20 November 2000 laying down specific provisions for the control and eradication of bluetongue(1), and in particular Article 9(2),

Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field(2), as last amended by Decision 2001/12/EC(3), and in particular Article 3(3) and (5),

Whereas:

(1) Commission Decision 2000/477/EC(4) provides a 500000 doses Community bank of trivalent bluetongue vaccine containing serotypes 4, 9 and 16.

(2) For technical reasons the laboratory producing the vaccine has proposed to the Commission, with no additional charge, to replace these by 500000 newly produced ones.

(3) This trivalent vaccine was intended to be used in Greece.

(4) Taking into consideration the epidemiological situation prevailing in Greece, the Greek authorities have confirmed they will not use this vaccine in the foreseeable future.

(5) It is more appropriate to replace these 500000 trivalent doses by 500000 doses of bivalent 2 and 9 vaccine which will be used in southern Italy, the Italian authorities having expressed their intention to vaccinate in these regions with that type of vaccine.

(6) The measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Committee,

HAS ADOPTED THIS DECISION:

Article 1

The 500000 doses bank of trivalent (4, 9 and 16) bluetongue vaccine provided for in Article 1(1) of Decision 2000/477/EC is restocked with 500000 doses of bivalent (2 and 9) bluetongue vaccine.

Article 2

This Decision is addressed to the Member States.

Done at Brussels, 11 February 2002.

For the Commission

David Byrne

Member of the Commission

(1) OJ L 327, 22.12.2000, p. 74.

(2) OJ L 224, 18.8.1990, p. 19.

(3) OJ L 3, 6.1.2001, p. 27.

(4) OJ L 187, 26.7.2000, p. 56.